DUBLIN--(BUSINESS WIRE)--Maven Semantic (http://www.mavensemantic.com) announces updates to their Novel Protein Target database.
The new database is now available to marketing, business development, competitor intelligence, KOL, medical affairs and related departments in the life sciences sector.
The database currently tags 92,000 individuals working with Novel Protein Targets. http://bit.ly/fNMCrn.
Top 10 Countries for Novel Protein Target Research (ranked by number of senior researchers)
- United States Of America (47,978)
- Japan (5,912)
- United Kingdom (5,262)
- Germany (5,182)
- Canada (2,998)
- Italy (2,596)
- China (2,340)
- France (2,013)
- Australia (1,592)
- The Netherlands (1,350)
Leading organisations in Novel Protein Target research include:
- Albert Einstein College of Medicine
- Baylor College of Medicine
- Beth Israel Deaconess Medical Center
- Boston University School of Medicine
- Brigham and Women's Hospital
- Case Western Reserve University
- Columbia University
- Cornell University
- Dana-Farber Cancer Institute
- Duke University Medical Center
- Fred Hutchinson Cancer Research Center
- Harvard Medical School
- Howard Hughes Medical Institute
- Indiana University School of Medicine
- Institut Pasteur
- Johns Hopkins University School of Medicine
- Karolinska Institutet
- Massachusetts General Hospital
- Massachusetts Institute of Technology
- Mayo Clinic College of Medicine
- Memorial Sloan-Kettering Cancer Center
- Merck Research Laboratories
- National Cancer Institute
- National Institutes of Health
- National University of Singapore
- Roswell Park Cancer Institute
- The Johns Hopkins University School of Medicine
- The Scripps Research Institute
- University of Alabama at Birmingham
- University of Alberta
- University of Cambridge
- University of Florida
- University of Glasgow
- University of Maryland School of Medicine
- University of Minnesota
- University of Oxford
- University of Pittsburgh
- University of Tokyo
- University of Toronto
- University of Virginia
- University of Washington
- Yale University School of Medicine
The database also includes pharmaceutical companies, biotech companies, CROs, hospitals, government labs and other organisations active in the Novel Protein Target research field.
Sample companies in database include:
- Amgen Inc
- AstraZeneca India Pvt. Ltd
- Avigen, Inc
- Basic Research Program, Inc
- Bayer HealthCare AG
- Biogen Idec, Inc
- Boehringer Ingelheim (Canada) Ltd
- Bristol-Myers Squibb Company
- Cell Signaling Technology, Inc
- Chiron Corporation
- Corixa Corporation
- Crucell Holland B.V
- Daiichi Sankyo Co., Ltd
- Diversa Corporation
- Eli Lilly and Company
- EntreMed, Inc
- F. Hoffmann-La Roche Ltd
- Genentech Inc
- Genzyme Corp
- Human Genome Sciences, Inc
- Immunomedics, Inc
- Infinity Pharmaceuticals, Inc
- Integrated Genomics, Inc
- Intercell AG
- Isis Pharmaceuticals, Inc
- Japan Science and Technology Corporation
- KuDOS Pharmaceuticals Ltd
- Kyowa Hakko Kogyo Co., Ltd
- Ligand Pharmaceuticals, Inc
- MedImmune, Inc
- Millennium Pharmaceuticals, Inc
- Mochida Pharmaceutical Co. Ltd
- New England Biolabs, Inc
- Novartis Institutes for Biomedical Research, Inc
- Novartis Pharma
- Nuvelo, Inc
- OSI PHARMACEUTICALS, INC
- Pfizer Inc
- Progenics Pharmaceuticals, Inc
- Regeneron Pharmaceuticals, Inc
- Rosetta Inpharmatics, LLC
- Sangamo BioSciences, Inc
- Yamanouchi Pharmaceutical Co., Ltd
What is Maven:
- Largest database of international medical professionals, with over 6,000,000 people and over 500,000 medical organisations;
- All records are downloadable to excel or in-house database, with email, postal address and phone contacts;
- Profile and segment the entire database using over 47,000 diseases and therapeutic areas
For more information visit http://www.mavensemantic.com/